← Open Payments lookup

KIMBERLY GLASS: Open Payments

NPI 1497119101 · GRIFFIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$433 in 22 payments from 13 companies in 2025. Trend: 2023 $634 · 2024 $510 · 2025 $433

Food & beverage: $433
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$72
Novo Nordisk Inc3$65
Sumitomo Pharma America, Inc.3$50
ABBVIE INC.2$44
GlaxoSmithKline, LLC.2$40
PFIZER INC.2$32
Noven Therapeutics, LLC1$25
Astellas Pharma US Inc1$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
Amgen Inc.1$18

Products named: AIRSUPRA, GEMTESA, Wegovy, ELIQUIS, QULIPTA, Xelstrym, Veozah, Ozempic.

Industry payments across GA — which companies pay providers there.